CHG (Stock Code: 673) Updates on Auditor’s Disclaimer of Opinion for FY2025

Bulletin Express

01/23

China Health Group Limited (CHG, Stock Code: 673) issued an update related to the auditor’s disclaimer of opinion on the Company’s consolidated financial statements for the year ended 31 March 2025. The Company indicated that it continues to address liquidity concerns and is implementing measures to resolve the going concern issue.

CHG has completed several financing initiatives, including subscriptions and a rights issue, which provided aggregate net proceeds of approximately HK$80.9 million in October 2025. The Board is also negotiating to renew the Group’s bank borrowing of approximately HK$5.4 million as at 31 March 2025 and targets finalizing these negotiations by the end of the first quarter of 2026.

The Company plans to provide updates every three months from 23 January 2026 until the auditor’s disclaimer is resolved. Shareholders and investors are advised to remain cautious when dealing in the Company’s securities.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1115472051"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1115472051\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1115472051?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-23 20:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1115472051","market":"us","top_or_hot":-1,"title":"CHG (Stock Code: 673) Updates on Auditor’s Disclaimer of Opinion for FY2025","media":"Bulletin Express","content":"<p>China Health Group Limited (CHG, Stock Code: 673) issued an update related to the auditor’s disclaimer of opinion on the Company’s consolidated financial statements for the year ended 31 March 2025. The Company indicated that it continues to address liquidity concerns and is implementing measures to resolve the going concern issue.</p>\n<p>CHG has completed several financing initiatives, including subscriptions and a rights issue, which provided aggregate net proceeds of approximately HK$80.9 million in October 2025. The Board is also negotiating to renew the Group’s bank borrowing of approximately HK$5.4 million as at 31 March 2025 and targets finalizing these negotiations by the end of the first quarter of 2026.</p>\n<p>The Company plans to provide updates every three months from 23 January 2026 until the auditor’s disclaimer is resolved. Shareholders and investors are advised to remain cautious when dealing in the Company’s securities.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CHG (Stock Code: 673) Updates on Auditor’s Disclaimer of Opinion for FY2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCHG (Stock Code: 673) Updates on Auditor’s Disclaimer of Opinion for FY2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-01-23 20:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China Health Group Limited (CHG, Stock Code: 673) issued an update related to the auditor’s disclaimer of opinion on the Company’s consolidated financial statements for the year ended 31 March 2025. The Company indicated that it continues to address liquidity concerns and is implementing measures to resolve the going concern issue.</p>\n<p>CHG has completed several financing initiatives, including subscriptions and a rights issue, which provided aggregate net proceeds of approximately HK$80.9 million in October 2025. The Board is also negotiating to renew the Group’s bank borrowing of approximately HK$5.4 million as at 31 March 2025 and targets finalizing these negotiations by the end of the first quarter of 2026.</p>\n<p>The Company plans to provide updates every three months from 23 January 2026 until the auditor’s disclaimer is resolved. Shareholders and investors are advised to remain cautious when dealing in the Company’s securities.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00673","symbol_name":"中国卫生集团","start_time":0,"source_url":"","article_id":"1115472051","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1115472051","pubTimestamp":1769171046,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Health Group Limited (CHG, Stock Code: 673) issued an update related to the auditor’s disclaimer of opinion on the Company’s consolidated financial statements for the year ended 31 March 2025....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00673":"中国卫生集团"},"translate_title":"CHG（股份代号：673）有关二零二五财政年度核数师不发表意见的更新","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00673":1},"content_text":"China Health Group Limited (CHG, Stock Code: 673) issued an update related to the auditor’s disclaimer of opinion on the Company’s consolidated financial statements for the year ended 31 March 2025. The Company indicated that it continues to address liquidity concerns and is implementing measures to resolve the going concern issue.\nCHG has completed several financing initiatives, including subscriptions and a rights issue, which provided aggregate net proceeds of approximately HK$80.9 million in October 2025. The Board is also negotiating to renew the Group’s bank borrowing of approximately HK$5.4 million as at 31 March 2025 and targets finalizing these negotiations by the end of the first quarter of 2026.\nThe Company plans to provide updates every three months from 23 January 2026 until the auditor’s disclaimer is resolved. Shareholders and investors are advised to remain cautious when dealing in the Company’s securities.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}